Switch to:

Latest Guru Trades with MASI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 25.30
MASI's P/E(ttm) is ranked higher than
88% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 201.60 vs. MASI: 25.30 )
MASI' s 10-Year P/E(ttm) Range
Min: 16.96   Max: 91.05
Current: 25.3

16.96
91.05
Forward P/E 21.98
MASI's Forward P/E is ranked higher than
88% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. MASI: 21.98 )
N/A
PE(NRI) 24.50
MASI's PE(NRI) is ranked higher than
88% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 140.40 vs. MASI: 24.50 )
MASI' s 10-Year PE(NRI) Range
Min: 17.04   Max: 66.16
Current: 24.5

17.04
66.16
P/B 5.60
MASI's P/B is ranked higher than
59% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 4.25 vs. MASI: 5.60 )
MASI' s 10-Year P/B Range
Min: 3.54   Max: 15.2
Current: 5.6

3.54
15.2
P/S 3.00
MASI's P/S is ranked higher than
72% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 3.68 vs. MASI: 3.00 )
MASI' s 10-Year P/S Range
Min: 1.77   Max: 9.79
Current: 3

1.77
9.79
PFCF 99.50
MASI's PFCF is ranked higher than
79% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. MASI: 99.50 )
MASI' s 10-Year PFCF Range
Min: 2.29   Max: 2642
Current: 99.5

2.29
2642
POCF 18.51
MASI's POCF is ranked higher than
87% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 78.33 vs. MASI: 18.51 )
MASI' s 10-Year POCF Range
Min: 2.16   Max: 51.16
Current: 18.51

2.16
51.16
EV-to-EBIT 16.11
MASI's EV-to-EBIT is ranked higher than
92% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 73.27 vs. MASI: 16.11 )
MASI' s 10-Year EV-to-EBIT Range
Min: 6.3   Max: 117.2
Current: 16.11

6.3
117.2
PEG 6.28
MASI's PEG is ranked higher than
91% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. MASI: 6.28 )
MASI' s 10-Year PEG Range
Min: 4.3   Max: 577.5
Current: 6.28

4.3
577.5
Shiller P/E 29.20
MASI's Shiller P/E is ranked higher than
93% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. MASI: 29.20 )
MASI' s 10-Year Shiller P/E Range
Min: 14.15   Max: 30.84
Current: 29.2

14.15
30.84
Current Ratio 2.54
MASI's Current Ratio is ranked higher than
71% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.51 vs. MASI: 2.54 )
MASI' s 10-Year Current Ratio Range
Min: 1.35   Max: 4.87
Current: 2.54

1.35
4.87
Quick Ratio 1.98
MASI's Quick Ratio is ranked higher than
71% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. MASI: 1.98 )
MASI' s 10-Year Quick Ratio Range
Min: 1.15   Max: 4.34
Current: 1.98

1.15
4.34
Days Inventory 113.00
MASI's Days Inventory is ranked higher than
81% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 166.67 vs. MASI: 113.00 )
MASI' s 10-Year Days Inventory Range
Min: 55.77   Max: 117.9
Current: 113

55.77
117.9
Days Sales Outstanding 44.19
MASI's Days Sales Outstanding is ranked higher than
93% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 79.87 vs. MASI: 44.19 )
MASI' s 10-Year Days Sales Outstanding Range
Min: 36.51   Max: 52.39
Current: 44.19

36.51
52.39

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 29.76
MASI's Price/Net Current Asset Value is ranked higher than
72% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 327.00 vs. MASI: 29.76 )
MASI' s 10-Year Price/Net Current Asset Value Range
Min: 6.27   Max: 24.62
Current: 29.76

6.27
24.62
Price/Tangible Book 6.48
MASI's Price/Tangible Book is ranked higher than
68% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 7.90 vs. MASI: 6.48 )
MASI' s 10-Year Price/Tangible Book Range
Min: 4.11   Max: 15.3
Current: 6.48

4.11
15.3
Price/DCF (Projected) 1.98
MASI's Price/DCF (Projected) is ranked higher than
90% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. MASI: 1.98 )
MASI' s 10-Year Price/DCF (Projected) Range
Min: 1.22   Max: 2.32
Current: 1.98

1.22
2.32
Price/Median PS Value 0.95
MASI's Price/Median PS Value is ranked higher than
85% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. MASI: 0.95 )
MASI' s 10-Year Price/Median PS Value Range
Min: 0.79   Max: 1.91
Current: 0.95

0.79
1.91
Price/Graham Number 2.54
MASI's Price/Graham Number is ranked higher than
87% of the 524 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. MASI: 2.54 )
MASI' s 10-Year Price/Graham Number Range
Min: 1.76   Max: 5.96
Current: 2.54

1.76
5.96
Earnings Yield (Greenblatt) 6.00
MASI's Earnings Yield (Greenblatt) is ranked higher than
91% of the 468 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. MASI: 6.00 )
MASI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.9   Max: 15.8
Current: 6

0.9
15.8
Forward Rate of Return (Yacktman) 2.62
MASI's Forward Rate of Return (Yacktman) is ranked higher than
75% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: 4.94 vs. MASI: 2.62 )
MASI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.6   Max: 14.1
Current: 2.62

-2.6
14.1

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:3M4.Germany,
Masimo Corp was incorporated in California in May 1989 and reincorporated in Delaware in May 1996. The Company is a medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Its core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, known as Masimo SET pulse oximetry, but our product offerings have expanded significantly over the years to also include noninvasive blood constituent, brain and breath monitoring, including rainbow Pulse CO-Oximetry, brain function electroencephalogram (EEG) monitoring, respiration rate, capnography and anesthetic agent monitoring. In addition, they have developed the Root patient monitoring and connectivity platform and Patient SafetyNet remote patient surveillance monitoring system. They provide their products directly and through distributors and OEM partners to hospitals, emergency medical service (EMS) providers, physician offices, veterinarians, long term care facilities and consumers. The Company sell their products to end-users through its direct sales force and certain distributors, as well as its OEM partners, for incorporation into their products. They also offer a patient surveillance or remote monitoring and clinician notification solution called Patient SafetyNet, which includes Masimo SET or rainbow SET platform measurements at the patient's bedside along with a central assignment station and wired or wireless server. In October 2012, they received both FDA clearance for uSpO2, a universal "Board-in-Cable" pulse oximetry solution, enabling easier and faster integration for OEM partners due to the ability to integrate Masimo SET through software only. The Company acquired Spire Semiconductor, LLC, a maker of advanced light emitting diode and other advanced component-level technologies. Masimo Semiconductor, Inc. (Masimo Semiconductor), its wholly owned subsidiary, operates this business and specializes in wafer epitaxy, foundry services, and device fabrication for biomedical, telecommunications, consumer products and other markets. The Company offer Masimo SET and rainbow SET through its OEMs for integration in their products and through its own end-user products, including the Root, Radical-7, Rad-87, Rad-57, Pronto-7, Pronto, Rad-8, Rad-5 and Rad-5v. The Company has 674 issued and pending patents worldwide. They have licensed from Cercacor Laboratories, Inc. (Cercacor), the right to OEM selected rainbow technology and to incorporate selected rainbow technology into their products intended to be used by professional caregivers, including, but not limited to, hospital caregivers and alternate care facility caregivers. The Company is subject to U.S. Food, Drug, and Cosmetic Act (FDCA) and the regulations promulgated under that Act, the FDA regulates the design, development, clinical trials, testing, manufacture, packaging, labeling, storage, distribution and promotio
» More Articles for NAS:MASI

Headlines

Articles On GuruFocus.com
Inova Fair Oaks Hospital Casts Masimo Patient SafetyNet(TM) to Help Improve Patient Outcomes and Red Jan 14 2015 
Masimo Unveils MightySat(TM) at Consumer Electronics Show -- First Fingertip Pulse Oximeter With Mas Jan 05 2015 
Masimo to Present at 33rd Annual J.P. Morgan Healthcare Conference Dec 30 2014 
Masimo Announces Global Launch of Multigas Monitoring for the Root(R) Patient Monitoring and Connect Dec 16 2014 
Masimo Receives 2014 Zenith Award at the American Association of Respiratory Care Congress Dec 10 2014 
Masimo iSpO2(TM) Pulse Oximeter Featured in Fitness Book by Tour de France Champion Greg LeMond Dec 04 2014 
Masimo Announces FDA 510(k) Clearance of Radius-7(TM) -- First rainbow(R) SET(R) Noninvasive Wearabl Dec 01 2014 
New Clinical Study Shows Accuracy of Masimo Noninvasive Spot-Check Hemoglobin (SpHb(R)) in Trauma Pa Nov 05 2014 
Arkansas Heart Hospital Upgrades to Masimo SET(R) Pulse Oximetry, Resulting in Significant Reduction Oct 23 2014 
Masimo to Report Third Quarter 2014 Financial Results After Market Close on Wednesday, October 29th Oct 17 2014 

More From Our Partners
Masimo's SedLine Monitor Selected By Penn Highlands - Analyst Blog Mar 27 2015 - ZACKS

More From Other Websites
Une nouvelle étude clinique présentée lors du congrès annuel de l'International Anesthesia... Mar 30 2015
New Clinical Study Presented at the International Anesthesia Research Society's Annual Meeting Shows... Mar 30 2015
8:03 am Masimo announces new clinical study presented at the International Anesthesia Research... Mar 30 2015
New Clinical Study Presented at the International Anesthesia Research Society's Annual Meeting Shows... Mar 30 2015
Masimo's SedLine Monitor Selected By Penn Highlands - Analyst Blog Mar 27 2015
Penn Highlands DuBois Installs Masimo SedLine Brain Function Monitoring Mar 26 2015
Penn Highlands DuBois Installs Masimo SedLine Brain Function Monitoring Mar 26 2015
La société Masimo présentera les solutions Root(R) destinées aux salles d'opération et aux... Mar 19 2015
Masimo to Showcase Root(R) Solutions for the OR and ICU at the International Anesthesia Research... Mar 19 2015
Masimo to Showcase Root(R) Solutions for the OR and ICU at the International Anesthesia Research... Mar 19 2015
Korean Regulators Clear Masimo PVI(R) for Clinical Use Mar 03 2015
Masimo to Present at 27th Annual ROTH Capital Partners Growth Stock Conference Mar 03 2015
Masimo to Present at 27th Annual ROTH Capital Partners Growth Stock Conference Mar 03 2015
Les régulateurs coréens autorisent l'utilisation clinique du PVI(R) de Masimo Feb 26 2015
Korean Regulators Clear Masimo PVI(R) for Clinical Use Feb 26 2015
Masimo to Present at 36th Annual Raymond James Institutional Investors Conference Feb 25 2015
CFSI Announces Masimo as Co-Sponsor of the Excellence in Fire Service-Based EMS Award Feb 25 2015
Masimo to Present at 36th Annual Raymond James Institutional Investors Conference Feb 25 2015
Masimo (MASI) is in Overbought Territory: What's Next? - Tale of the Tape Feb 25 2015
MASIMO CORP Files SEC form 8-K, Change in Directors or Principal Officers Feb 24 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK